CoQ10 Blood Levels Clinical Trial
Official title:
An Open Label Pilot Study to Evaluate the Effectiveness of Omega Q Plus® Resveratrol at Increasing Blood Levels of CoQ10 in Healthy Subjects and Subjects on Statins
The primary objective of this study is to assess the blood levels of Coenzyme Q10 in healthy
subjects when administered Omega Q Plus® Resveratrol for 28 days.The secondary objective of
the study is to determine if statin use has an impact on the blood levels of Coenzyme Q10
when administered Omega Q Plus® Resveratrol for 28 days. The safety objectives will include
assessment of safety evaluations as determined by:
- laboratory tests - CBC, electrolytes (Na, K, Cl), glucose, creatinine, AST, ALT, GGT,
and bilirubin
- vital signs - heart rate and blood pressure
- adverse events
n/a
Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science